Key Record Dates Identifier: NCT04070768
Brief Title: Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113

First Submitted : August 26, 2019
First Submitted that Met QC Criteria : August 26, 2019
First Posted : August 27, 2019 (Estimate)

Last Update Submitted that Met QC Criteria : November 12, 2019
Last Update Posted : November 13, 2019